Recent Finacing
Recent Raise
Cristal Therapeutics develops CriPec® polymer nanoparticles to encapsulate oncology and oligonucleotide drugs, improving distribution and selective release; lead CriPec® docetaxel is progressing through clinical studies and DUO dual-drug programs.
